Literature DB >> 25038598

Fractionated plasmatic separation and adsorption does not alter haemodynamic parameters in experimental acute liver failure.

Eva Laszikova1, Josef Prazak2, Ondrej Ryska3, Eva Koblihova3, Tomas Tyll1, Miroslav Ryska3.   

Abstract

OBJECTIVE: Acute liver failure (ALF) is a rare disease with a bad prognosis. Its start is accompanied by haemodynamic instability. The aim of our study was to evaluate the influence of fractionated plasmatic separation and adsorption (FPSA) on body haemodynamics using a large animal experimental model of ALF.
METHODS: ALF was induced by the devascularisation of 21 laboratory pigs. FPSA was applied in 14 animals and seven animals formed a control group. Values of systemic vascular resistance index (SVRI), heart rate (HR), pulmonary artery wedge pressure (PAWP) and cardiac index (CI) at hours 3, 6, 9 and 12 of the experiment were compared. The values from laboratory tests conducted with FPSA-treated vs. untreated ALF animals were compared using Student's t-test, paired or unpaired, as required, and Mann-Whitney U-test using EXCEL and QUATRO spreadsheet applications.
RESULTS: We found no significant differences in mean arterial pressure, SVRI, or plasma lactate (p>0.05) in the FPSA-treated group but there was a significant decrease(p<0.05) in intracranial pressure (ICP). Furthermore, we observed a significant decrease in HR at hour 3. A significant increase in CI at hour 9 and a significant decrease in pulmonary artery wedge pressure at hours 6 and 12 were also observed.
CONCLUSION: Our study of FPSA application (Prometheus device) for treatment of experimental ALF in a large animal model did not confirm the earlier reported development of changes in body haemodynamics.

Entities:  

Mesh:

Year:  2014        PMID: 25038598

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

1.  Changes in cellular proliferation and plasma products are associated with liver failure.

Authors:  Juliana Gil Melgaço; Frederico Marianetti Soriani; Pedro Henrique Ferreira Sucupira; Leonardo Assaf Pinheiro; Yasmine Rangel Vieira; Jaqueline Mendes de Oliveira; Lia Laura Lewis-Ximenez; Cristina Carvalho Vianna Araújo; Lúcio Filgueiras Pacheco-Moreira; Gustavo Batista Menezes; Oswaldo Gonçalves Cruz; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  World J Hepatol       Date:  2016-11-18

2.  Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery.

Authors:  Ekaterina Komardina; Michael Yaroustovsky; Marina Abramyan; Marina Plyushch
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20

Review 3.  End-stage liver failure: filling the treatment gap at the intensive care unit.

Authors:  Robert A F M Chamuleau; Ruurdtje Hoekstra
Journal:  J Artif Organs       Date:  2019-09-18       Impact factor: 1.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.